Cancer and non-cancer risk assessment should be harmonized

Human and Ecological Risk Assessment (HERA)

Volumn 3, Issue 4, 1997, Pages 495-499

  Crump, Kenny S ^a,c   Clewell, Harvey J ^a,c   Andersen, Melvin E ^b,d  

^a IGF Kaiser International   (United States)

^b ICF Kaiser Engineers Inc   (United States)

^c ICF INTERNATIONAL   (United States)

^d ICF Kaiser   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21944450575     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807039709383703     Document Type: Article

References (13)

1. REFERENCES Allen, B., Kimmel, C., Kavlock, R., and Faustman, E. 1994. Dose-response assessment for development toxicity. II. Comparison of generic benchmark dose estimates with NOAELs. Fund Appl Toxicol 23, 487-495.
2. Andersen, M.E., Mills, J.J., Jirtle, R.J., and Greenlee, W.F. 1995. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102, 233-237.
3. Beck, B.D., Conolly, R.B., Dourson, M.L., Guth, D., Hattis, D., Kimmel, C., and Lewis, S.C. 1993. Improvements in quantitative noncancer risk assessment. Fundam. Appl. Toxicol. 20, 1-14.
4. Crump, K. 1984. A new method for determining allowable daily intakes. Fund Appl Toxicol 4, 854-871.
5. Crump, K. 1995. Calculation of benchmark doses from continuous data. Risk Anal 15, 79-89.
6. Crump, K., Hoel, D., Langley, C., and Peto, R. 1976. Fundamental carcinogenic processes and their implications to low dose risk assessment. Cancer Res 36, 2973-2979.
7. Crump, K., Haseman, J., Krewski, D., and Wang, Y. 1996. Estimates of the number of liver carcinogens in bioassays conducted by the National Toxicology Program. Abstract for the Annual Meeting of the Society of Toxicology, Anaheim, California, March 10-14, 1996.
8. USEPA (US Environmental Protection Agency). 1992. Request for comments on draft report of cross-species scaling factor for cancer risk assessment. Fed. Reg. 57 (1992) 24152.
9. USEPA (US Environmental Protection Agency). 1994. Health assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. EPA/600/BP-92/001.
10. USEPA (US Environmental Protection Agency). 1996. Proposed guidelines for carcinogen risk assessment. EPA/600/P-92/003C.
11. Larson, J.L., Wolf, D.C., and Butterworth, B.E. 1994. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by garage in corn oil vs. ad libitum in drinking water. Fundam Appl Toxicol 22, 90-102.
12. National Research Council (NRC). 1977. Safe Drinking Water and Health. National Academy of Sciences, Washington, DC.
13. Reitz RH, Mendrala AL, Corley RA, Quast JF, Gargas ML, Andersen ME, Staats DA, and Conolly RB. 1990. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. Toxicol. Appl. Pharmacol. 105, 443-459.